Breast Implants Lymphoma Cancer
In a rush? You can use our Quick Contact Form to tell us the basic information about your case.
The Law Offices of Thomas J. Lamb represents people who have been harmed by unsafe medical products, including cases involving breast implants associated with lymphoma.
In more detail, the US Food and Drug Administration (FDA) has received reports about women who have had breast implant procedures done and, later, were diagnosed with these medical conditions:
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
- Anaplastic Large Cell Lymphoma (ALCL)
- Non-Hodgkin Lymphoma (also known as Non-Hodgkin’s Lymphoma, NHL, or just Lymphoma)
- T-cell Lymphoma
We encourage you to submit a Breast Implants Cancer Case Review – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible breast implants case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, nor some other lawyer — about your case based on his many years of experience.
- Summary of Information
- The Disease
- FDA Information
- Frequently Asked Questions
➤ About the Disease
➤ Risk Factors
We are here to help the women and families who have experienced this unfortunate situation. We have successfully handled personal injury and wrongful death cases for people throughout the country.
Our firm does not put its clients into large class actions lawsuits. Rather, an individual lawsuit is filed for each case. There are no costs associated with having us review your possible breast implants case.
Be assured that the information you provide to our law firm is treated as strictly confidential. Submitting a case evaluation does not obligate you to hire our law firm.
Lastly, we want you to know that you will get a reply directly from attorney Tom Lamb no later than the next business day.
Most Recent Article on This Topic
As you may know from our previous articles, specific kinds of textured breast implants have been banned and recalled in countries due to their link to a cancer called Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). France, Canada, and Australia have banned Allergan’s textured breast implants and the U.S. FDA has recalled them. Allergan has withdrawn their textured implants from the market worldwide.
Background of BIA-ALCL Statistics
BIA-ALCL began as a rare form of cancer. But, in April 2019, we brought to attention the new statistics for BIA-ALCL diagnoses in our article, “Textured Breast Implants Bans on the Rise“. As of February, the total number of cases had grown from 359 to 457 in the U.S. and about 700 worldwide, with the number of deaths rising from 9 to 16.
To read more of this article, click below:
In Canada, their governmental health agency called Health Canada published an alert in February 2019 stating that they had received reports of 22 confirmed cases and 22 suspected cases. Whereas the initial review in 2017 showed only 5 confirmed cases in the last 10 years. The recent CBC News article, “‘An emerging malignancy’: Cancer linked to these breast implants no longer ‘rare’, data suggests,” states the most recent update,
As of Dec. 20, 2019, Health Canada said it had received 106 reports describing ‘breast implant-associated anaplastic large cell lymphoma (BIA-ALCL),’ including both confirmed and suspected cases. Of those, 52 were received since May 28, 2019.
With the information that has become available on the link between these breast implants and BIA-ALCL, more women are presenting concerns to their doctors and more diagnoses are being made. Health professionals around the world are analyzing this information and believe that official statistics do not accurately represent the growing number of cases.
UK Regulators Still Not Banning
Though the evidence on the dangers of this link is high, regulators in the UK have not made any moves to ban the implants. According to the recent article from The Guardian, “Anger over UK’s failure to ban breast implants linked to 61 cancer cases,” the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has claimed the disease to be very rare. The article quotes an MHRA spokesperson who said,
[Read article in full at original source]
Based on our analysis of the latest scientific evidence and expert clinical input, our advice remains unchanged: there is no new evidence of an increased risk to patients and there is no need for people with breast implants to have them removed in the absence of any symptoms.
Our earlier articles about this breast implants lymphoma cancer situation:
- FDA Proposes New Recommendations for Breast Implant Labels
- TGA Regulations on Breast Implant Products
- FDA Recalls Allergan Textured Implants
- Statistics Show An Increased Risk For BIA-ALCL With Textured Implants
- Textured Breast Implants Ban: Onto Australia
- FDA Fails When It Comes To Banning Textured Breast Implants
- Textured Breast Implants Bans on the Rise
- March 2019 FDA Meeting On Breast Implants: A Summary Of What You Need To Know
- Breast Implants FDA March 2019 Meeting: Lymphoma Cancer Was A Main Topic
- 2019 Discoveries and Warnings on Breast Implant-Associated Lymphoma
- Breast Implants Lymphoma Cancer Cases Update February 2019 – US & Canada
- Allergan Textured Breast Implants Recalled In Europe Due To BIA-ALCL
- FDA Provides Updated Number of Breast Implants Lymphoma Cancers
- New Data Released on Risk of Lymphoma Due to Breast Implants
- Breast Implant-Associated Lymphoma Diagnoses on the Rise
- What is the Risk of Death Due to Breast Implant-Associated Lymphoma?
- Treatments For Breast Implants Associated Lymphoma And Blood Cancer
- Breast Implants and Lymphoma: Who’s to Blame?
- Breast Implants Lymphoma Cancer: Diagnosis And Treatment Developments
- Breast Implant Lymphoma: Causes Uncertain, but Costs Undeniable
- March 2017 FDA Report: Breast Implants Linked To Lymphoma Blood Cancer
- Breast Implants Linked to Rare Lymphoma Blood Cancer